Abstract Book Now Available

The 32nd National Medicinal Chemistry Symposium took place on the campus of the University of Minnesota, Twin Cities Campus in Minneapolis.  A total of 359 participants joined us for the 4 day symposium.  Participants representing industry and academia, included scientists ranging from graduate student to the most accomplished leaders in the field.  We hope you enjoyed your time spent in Minneapolis and look forward to seeing you at the next meeting.  

Sessions (note full schedule on left hand navigation bar--all symposium events take place in Willey Hall)

1. Targeting Neurodegeneration
2. GPR119 as a Target for the Treatment of Type 2 Diabetes
   
3. Apoptosis Based Therapies
   
4. Natural product based-drug design
   
5. Recent Advances in Drug Metabolism and Pharmacokinetics
   
6. Recent Advances in Scale Up and Process Chemistry
   
7. Fragment Based Drug Discovery
   

Program Hosts include:

Carston R. Wagner, Ph.D.
General Chair of the 2010 Symposium
Professor, Department of Medicinal Chemistry
University of Minnesota

David Rotella, Ph.D., Program Chair
Principal Scientist, Pfizer

Yusuf Abul-Hajj, Ph.D., Program Chair
Professor of Medicinal Chemistry
University of Minnesota

Gunda Georg, Ph.D., Honorary Co-Chair
Professor and Department Head
Robert Vince Endowed Chair
McKnight Presidential Chair in
Medicinal Chemistry
University of Minnesota
Director, Institute for Therapeutics
Discovery and Development     

Philip S. Portoghese, Ph.D., Honorary Co-Chair
Distinguished Professor
Department of Medicinal Chemistry
University of Minnesota
Editor in Chief, Journal of Medicinal Chemistry